Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Stevens

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|November 5, 1997
Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell diseaseC Pászty, C M Brion, E Manci, et al.
Nature Genetics|September 1, 1995
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescueC Pászty, N Mohandas, M E Stevens, et al.
The Journal of Cell Biology|May 16, 2001
Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbetaY Hirai, D Radisky, R Boudreau, et al.
Science (New York, N.Y.)|August 9, 1996
Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and cR E Link, K Desai, L Hein, et al.
Development (Cambridge, England)|June 1, 1994
Pleiotropic effects of the mouse lethal yellow (Ay) mutation explained by deletion of a maternally expressed gene and the simultaneous production of agouti fusion RNAsD M Duhl, M E Stevens, H Vrieling, et al.
Cell|September 10, 1993
Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic miceD A Dedera, E K Waller, D P LeBrun, et al.
Nature Genetics|October 3, 1999
Functional screening of an asthma QTL in YAC transgenic miceD J Symula, K A Frazer, Y Ueda, et al.
Transplantation Proceedings|February 1, 1989
Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipientsM C Venning, T W Lennard, M E Stevens, et al.
BMJ (Clinical Research Ed.)|February 22, 1992
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal diseaseM E Stevens, G P Summerfield, A A Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effectsD K Rohrer, K H Desai, J R Jasper, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|November 5, 1997
Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell diseaseC Pászty, C M Brion, E Manci, et al.
Nature Genetics|September 1, 1995
Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescueC Pászty, N Mohandas, M E Stevens, et al.
The Journal of Cell Biology|May 16, 2001
Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbetaY Hirai, D Radisky, R Boudreau, et al.
Science (New York, N.Y.)|August 9, 1996
Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and cR E Link, K Desai, L Hein, et al.
Development (Cambridge, England)|June 1, 1994
Pleiotropic effects of the mouse lethal yellow (Ay) mutation explained by deletion of a maternally expressed gene and the simultaneous production of agouti fusion RNAsD M Duhl, M E Stevens, H Vrieling, et al.
Cell|September 10, 1993
Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic miceD A Dedera, E K Waller, D P LeBrun, et al.
Nature Genetics|October 3, 1999
Functional screening of an asthma QTL in YAC transgenic miceD J Symula, K A Frazer, Y Ueda, et al.
Transplantation Proceedings|February 1, 1989
Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipientsM C Venning, T W Lennard, M E Stevens, et al.
BMJ (Clinical Research Ed.)|February 22, 1992
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal diseaseM E Stevens, G P Summerfield, A A Hall, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effectsD K Rohrer, K H Desai, J R Jasper, et al.
Pageof 4